TRAVERE THERAPEUTICS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2014 | — | $-37.3M | $18.2M |
| FY2015 | — | $300.0M | $37.8M |
| FY2016 | — | $307.8M | $41.0M |
| FY2017 | — | $293.1M | $99.4M |
| FY2018 | — | $318.3M | $102.9M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2014 | — | $-37.3M | $18.2M |
| FY2015 | — | $300.0M | $37.8M |
| FY2016 | — | $307.8M | $41.0M |
| FY2017 | — | $293.1M | $99.4M |
| FY2018 | — | $318.3M | $102.9M |